Growth Metrics

Iridex (IRIX) Current Deferred Revenue (2016 - 2025)

Iridex (IRIX) has 15 years of Current Deferred Revenue data on record, last reported at $2.2 million in Q3 2025.

  • For Q3 2025, Current Deferred Revenue fell 5.44% year-over-year to $2.2 million; the TTM value through Sep 2025 reached $2.2 million, down 5.44%, while the annual FY2024 figure was $2.2 million, 82.49% down from the prior year.
  • Current Deferred Revenue reached $2.2 million in Q3 2025 per IRIX's latest filing, down from $2.3 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $14.9 million in Q3 2022 and bottomed at $1.2 million in Q1 2021.
  • Average Current Deferred Revenue over 5 years is $6.7 million, with a median of $2.4 million recorded in 2022.
  • Peak YoY movement for Current Deferred Revenue: soared 982.72% in 2022, then plummeted 84.67% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $12.4 million in 2021, then grew by 13.69% to $14.2 million in 2022, then decreased by 12.18% to $12.4 million in 2023, then crashed by 82.49% to $2.2 million in 2024, then rose by 1.47% to $2.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $2.2 million in Q3 2025, $2.3 million in Q2 2025, and $2.1 million in Q1 2025.